Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby M Maher

Showing results (21-30 of 391) with videos related to

Pageof 40
Sort By:
Seminars in Respiratory and Critical Care Medicine|March 27, 2014
Immunosuppression for connective tissue disease-related pulmonary diseaseToby M Maher
JAMA|April 22, 2024
Interstitial Lung Disease: A ReviewToby M Maher
Respirology (Carlton, Vic.)|April 7, 2025
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non-Responders in IPF?Toby M Maher
F1000Research|June 16, 2016
Recent advances in understanding idiopathic pulmonary fibrosisCécile Daccord, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|March 6, 2024
A Long and Winding Road: Drug Development in Idiopathic Pulmonary FibrosisPaolo Spagnolo, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
<i>Fatum Inexorabile</i>: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?Michael Kreuter, Toby M Maher
The Lancet. Respiratory Medicine|April 17, 2017
Clinical trial research in focus: why do so many clinical trials fail in IPF?Paolo Spagnolo, Toby M Maher
The Lancet. Respiratory Medicine|April 3, 2019
Can monocytes predict prognosis of idiopathic pulmonary fibrosis?Michael Kreuter, Toby M Maher
Respirology (Carlton, Vic.)|July 6, 2017
Cough in fibrotic lung disease: An unresolved challengePeter Saunders, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|January 25, 2020
Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to ArmsMichael Kreuter, Toby M Maher
Pageof 40

Showing results (21-30 of 391) with videos related to

Sort By:
Pageof 40
Seminars in Respiratory and Critical Care Medicine|March 27, 2014
Immunosuppression for connective tissue disease-related pulmonary diseaseToby M Maher
JAMA|April 22, 2024
Interstitial Lung Disease: A ReviewToby M Maher
Respirology (Carlton, Vic.)|April 7, 2025
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non-Responders in IPF?Toby M Maher
F1000Research|June 16, 2016
Recent advances in understanding idiopathic pulmonary fibrosisCécile Daccord, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|March 6, 2024
A Long and Winding Road: Drug Development in Idiopathic Pulmonary FibrosisPaolo Spagnolo, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
<i>Fatum Inexorabile</i>: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?Michael Kreuter, Toby M Maher
The Lancet. Respiratory Medicine|April 17, 2017
Clinical trial research in focus: why do so many clinical trials fail in IPF?Paolo Spagnolo, Toby M Maher
The Lancet. Respiratory Medicine|April 3, 2019
Can monocytes predict prognosis of idiopathic pulmonary fibrosis?Michael Kreuter, Toby M Maher
Respirology (Carlton, Vic.)|July 6, 2017
Cough in fibrotic lung disease: An unresolved challengePeter Saunders, Toby M Maher
American Journal of Respiratory and Critical Care Medicine|January 25, 2020
Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to ArmsMichael Kreuter, Toby M Maher
Pageof 40